Cargando…
Phalangeal Fracture During Attempted Dupuytrens Release Following Clostridial Collagenase Injection: Case Report
INTRODUCTION: Dupuytren’s disease can be a challenging condition for both patients and surgeons. Injectable collagen clostridium histolyticum was approved for clinical use by the Food and Drug Administration in 2010. A number of side effects have been described. In this case report, we present a com...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Indian Orthopaedic Research Group
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702696/ https://www.ncbi.nlm.nih.gov/pubmed/29181346 http://dx.doi.org/10.13107/jocr.2250-0685.832 |